Skip to main content
. 2016 Aug 24;6:31992. doi: 10.1038/srep31992

Table 2. Clinical data of patients with IgA nephropathy (non-crescentic IgA-GN (IgA-GN) and cellular-crescentic IgA-GN (crescentic IgA-GN)) and controls. If no unit is given data are presented as total count, otherwise as median (25th/75th percentile).

  IgA-GN; n = 5 Crescentic-IgA-GN; n = 5 Controls; n = 5
Female 2 3 4
Age at biopsy 47.0 (37.0/51.0) 46.0 (17.0/65.0) 37.0 (24.0/55.0)
Crescents per total glomeruli count (%) 0 (0/0) 44.4 (36.6/46.2) 0 (0/0)
Global glomerulosclerosis per total glomeruli count (%) 5.9 (5.9/6.3) 9.8 (0/10) 0 (0/0)
Arterial hypertension WHO-Grade
 0 3 2 3
 1 1 2 1
 2 1 0 0
 3 0 1 0
 n.d. 0 0 1
Proteinuria
 normal 0 0 2
 <3.5 g/day 5 3 3
 >3.5 g/day 0 2 0
 n.d. 0 0 0
Microhematuria 5 4 2
Macrohematuria 1 1 0
Haemoglobin (g/dl) 13.1 (11.1/15.4) 10.9 (10.8/12.7) 12.5 (9.1/14.1)
Leukocytes (103/μl) 6.8 (5.6/7.4) 8.1 (7.7/8.8) 8.8 (5.7/11.3)
Thrombocytes (103/μl) 237 (192/257) 360 (292/401) 245 (166/484)
Serum-Creatinine (μmol/l) 84 (68/232) 107 (79/450) 273 (129/465)
eGFR MDRD (ml/min) (Schwartz if age <18 years) 88.8 (42.2/96.0) 54.7 (22.1/95.5) 18.0 (15.8/40.8)

Although serum creatinine of controls was higher than those in patients with IgA nephropathy, there were no significant differences. Furthermore, there were no significant differences for eGFR (Steel-Dwass test).